shutterstock_1226709739_denphotos

DenPhotos / Shutterstock.com

14 September 2023Big PharmaMarisa Woutersen

US Court of Appeals sides with Apple in Masimo dispute

Court upholds USPTO and the PTAB decisions over blood-oxygen sensor in smartwatches | Ruling finds Masimo patents to be unpatentable and obvious | Only one claim relating to inconsistency to be reversed.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Could Apple face an ITC import ban of its watches?

17 January 2023 With wearable health monitoring technology booming, Apple is facing several challenges to its smartwatch patents from medtech firms, and ITC investigations threatening import bans in the US. Sarah Speight reports.

article

Apple suffers another bruising in smartwatch tech clash

31 January 2023 Tech giant faces second setback in a month in dispute with Masimo | Patent Trial and Appeals Board denies its request for IPR.

More on this story

Could Apple face an ITC import ban of its watches?

17 January 2023 With wearable health monitoring technology booming, Apple is facing several challenges to its smartwatch patents from medtech firms, and ITC investigations threatening import bans in the US. Sarah Speight reports.

article

Apple suffers another bruising in smartwatch tech clash

31 January 2023 Tech giant faces second setback in a month in dispute with Masimo | Patent Trial and Appeals Board denies its request for IPR.

More on this story

Could Apple face an ITC import ban of its watches?

17 January 2023 With wearable health monitoring technology booming, Apple is facing several challenges to its smartwatch patents from medtech firms, and ITC investigations threatening import bans in the US. Sarah Speight reports.

article

Apple suffers another bruising in smartwatch tech clash

31 January 2023 Tech giant faces second setback in a month in dispute with Masimo | Patent Trial and Appeals Board denies its request for IPR.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent